These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 35301175

  • 1. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
    Chen W, Zhang Y, Fang Z, Qi W, Xu Y.
    Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
    [Abstract] [Full Text] [Related]

  • 2. TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9.
    Xu Y, Yang Q, Fang Z, Tan X, Zhang M, Chen W.
    Comput Math Methods Med; 2022 May; 2022():6058720. PubMed ID: 35912155
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
    Li WQ, Zhang JP, Wang YY, Li XZ, Sun L.
    Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
    [Abstract] [Full Text] [Related]

  • 4. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG, Pan YW, Feng J, Zeng CT, Zhao XQ, Liang B, Zhang WW.
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.
    Dai HY, Ma Y, Da Z, Hou XM.
    Pathol Res Pract; 2018 Aug; 214(8):1130-1135. PubMed ID: 29929749
    [Abstract] [Full Text] [Related]

  • 6. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y, Song Y, Yan S, Cao M, Huang J, Jia D, Liu Y, Zhang S, Fan W, Cai L, Li C, Xing Y.
    Aging (Albany NY); 2020 Oct 25; 12(20):20047-20068. PubMed ID: 33099540
    [Abstract] [Full Text] [Related]

  • 7. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
    Chen Y, Guo Y, Yang H, Shi G, Xu G, Shi J, Yin N, Chen D.
    Oncotarget; 2015 Sep 15; 6(27):23708-19. PubMed ID: 26247633
    [Abstract] [Full Text] [Related]

  • 8. Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer.
    Li J, Gao L, Wang A, Qian H, Zhu J, Ji S, Chen J, Liu Z, Ji C.
    Cancer Med; 2023 Apr 15; 12(8):9826-9842. PubMed ID: 36846934
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
    Huo W, Zhu XM, Pan XY, Du M, Sun Z, Li ZM.
    Math Biosci Eng; 2019 May 23; 16(5):4607-4621. PubMed ID: 31499680
    [Abstract] [Full Text] [Related]

  • 10. KIFC1 aggravates non-small-cell lung cancer cell proliferation and metastasis via provoking TGF-β/SMAD signal.
    Liu Y, Ye W, Miao X, Wang X.
    Cell Mol Biol (Noisy-le-grand); 2023 Dec 20; 69(14):293-299. PubMed ID: 38279416
    [Abstract] [Full Text] [Related]

  • 11. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-β/SMAD and PI3K/AKT pathways.
    Guan L, Zhang L, Wang T, Jia L, Zhang N, Yan H, Zhao K.
    Cancer Biomark; 2021 Dec 20; 32(3):293-302. PubMed ID: 34151840
    [Abstract] [Full Text] [Related]

  • 12. Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis.
    Wang M, Ding X, Fang X, Xu J, Chen Y, Qian Y, Zhang J, Yu D, Zhang X, Ma X, Zhu T, Gu J, Zhang X.
    Mol Cancer; 2024 Jun 18; 23(1):128. PubMed ID: 38890620
    [Abstract] [Full Text] [Related]

  • 13. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
    Zhang Y, Zeng Y, Liu T, Du W, Zhu J, Liu Z, Huang JA.
    Respir Res; 2019 Jul 22; 20(1):164. PubMed ID: 31331328
    [Abstract] [Full Text] [Related]

  • 14. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR, Han SY, Li XH, Zheng WX, Pang LN, Jiang ST, Li PP.
    J Ethnopharmacol; 2017 May 23; 204():45-57. PubMed ID: 28412214
    [Abstract] [Full Text] [Related]

  • 15. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L, Yang H, Lei Z, Zhao J, Chen Y, Chen P, Li C, Zeng Y, Liu Z, Liu X, Zhang HT.
    Oncogene; 2016 Feb 18; 35(7):867-77. PubMed ID: 25961934
    [Abstract] [Full Text] [Related]

  • 16. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
    Sun Z, Su Z, Zhou Z, Wang S, Wang Z, Tong X, Li C, Wang Y, Chen X, Lei Z, Zhang HT.
    FASEB J; 2022 May 18; 36(5):e22283. PubMed ID: 35344216
    [Abstract] [Full Text] [Related]

  • 17. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H, Xu Z, Li C, Xu C, Lei Z, Zhang HT, Zhao J.
    Lung Cancer; 2016 Jul 18; 97():87-94. PubMed ID: 27237033
    [Abstract] [Full Text] [Related]

  • 18. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
    Chen H, Yang T, Lei Z, Wang L, Yang H, Tong X, Yang WT, Zhao J, Gu Y, Chen Y, Zhang HT.
    Lung Cancer; 2015 Oct 18; 90(1):32-40. PubMed ID: 26238425
    [Abstract] [Full Text] [Related]

  • 19. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
    Wang L, Shang X, Feng Q.
    Cancer Biol Ther; 2019 Oct 18; 20(3):261-271. PubMed ID: 30481109
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L, Cheng Y, Zou S, Song J.
    Thorac Cancer; 2020 Feb 18; 11(2):264-276. PubMed ID: 31793741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.